Literature DB >> 22252773

Acceptance and importance of clinical pharmacists' LIMM-based recommendations.

Asa Bondesson1, Lydia Holmdahl, Patrik Midlöv, Peter Höglund, Emmy Andersson, Tommy Eriksson.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the quality of the clinical pharmacy service in a Swedish hospital according to the Lund Integrated Medicine Management (LIMM) model, in terms of the acceptance and clinical significance of the recommendations made by clinical pharmacists.
METHOD: The clinical significance of the recommendations made by clinical pharmacists was assessed for a random sample of inpatients receiving the clinical pharmacy service in 2007. Two independent physicians retrospectively ranked the recommendations emerging from errors in the patients' current medication list and actual drug-related problems according to Hatoum, with rankings ranging between 1 (adverse significance) and 6 (extremely significant).
RESULTS: The random sample comprised 132 patients (out of 800 receiving the service). The clinical significance of 197 recommendations was assessed. The physicians accepted and implemented 178 (90%) of the clinical pharmacists' recommendations. Most of these recommendations, 170 (83%), were ranked 3 (somewhat significant) or higher.
CONCLUSION: This study provides further evidence of the quality of the LIMM model and confirms that the inclusion of clinical pharmacists in a multi-professional team can improve drug therapy for inpatients. The very high level of acceptance by the physicians of the pharmacists' recommendations further demonstrates the effectiveness of the process.

Entities:  

Mesh:

Year:  2012        PMID: 22252773     DOI: 10.1007/s11096-012-9609-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  8 in total

Review 1.  Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities.

Authors:  J M Overhage; A Lukes
Journal:  Am J Health Syst Pharm       Date:  1999-12-01       Impact factor: 2.637

2.  Development of a quality use of medicines coding system to rate clinical pharmacists' medication review recommendations.

Authors:  Lene Sorensen; Mendel P Grobler; Michael S Roberts
Journal:  Pharm World Sci       Date:  2003-10

3.  Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction.

Authors:  H T Hatoum; R A Hutchinson; K W Witte; G P Newby
Journal:  Drug Intell Clin Pharm       Date:  1988-03

4.  Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review.

Authors:  Timothy F Chen; Abilio C de Almeida Neto
Journal:  Pharm World Sci       Date:  2007-05-04

5.  Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits.

Authors:  Lina M Hellström; Asa Bondesson; Peter Höglund; Patrik Midlöv; Lydia Holmdahl; Eva Rickhag; Tommy Eriksson
Journal:  Eur J Clin Pharmacol       Date:  2011-02-12       Impact factor: 2.953

6.  Outcomes of recommendations by hospice pharmacists.

Authors:  Jerome Lee; Mary Lynn McPherson
Journal:  Am J Health Syst Pharm       Date:  2006-11-15       Impact factor: 2.637

7.  An innovative approach to integrated medicines management.

Authors:  Claire Scullin; Michael G Scott; Anita Hogg; James C McElnay
Journal:  J Eval Clin Pract       Date:  2007-10       Impact factor: 2.431

8.  Evaluation of pharmacist clinical interventions in a Dutch hospital setting.

Authors:  Liesbeth Bosma; Frank G A Jansman; Anton M Franken; Johannes W Harting; Patricia M L A Van den Bemt
Journal:  Pharm World Sci       Date:  2007-06-26
  8 in total
  17 in total

1.  Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems.

Authors:  Sara Modig; Lydia Holmdahl; Åsa Bondesson
Journal:  Int J Clin Pharm       Date:  2015-11-18

Review 2.  Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review.

Authors:  Thi-Ha Vo; Bruno Charpiat; Claire Catoire; Michel Juste; Renaud Roubille; François-Xavier Rose; Sébastien Chanoine; Jean-Luc Bosson; Ornella Conort; Benoît Allenet; Pierrick Bedouch
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

3.  Risk of prescribing errors in acutely admitted patients: a pilot study.

Authors:  Dorthe Krogsgaard Bonnerup; Marianne Lisby; Eva Aggerholm Sædder; Charlotte Arp Sørensen; Birgitte Brock; Ljubica Andersen; Anette Gjetrup Eskildsen; Lars Peter Nielsen
Journal:  Int J Clin Pharm       Date:  2016-07-09

4.  Validation of pharmacist-physician collaboration in psychiatry: 'the Eichberger-model'.

Authors:  Martina Hahn; Christoph Ritter; Sibylle C Roll
Journal:  Int J Clin Pharm       Date:  2018-05-23

5.  Errors in medication history at hospital admission: prevalence and predicting factors.

Authors:  Lina M Hellström; Åsa Bondesson; Peter Höglund; Tommy Eriksson
Journal:  BMC Clin Pharmacol       Date:  2012-04-03

Review 6.  Clinical Pharmacy Services in Older Inpatients: An Evidence-Based Review.

Authors:  Lorenz Van der Linden; Julie Hias; Karolien Walgraeve; Johan Flamaing; Jos Tournoy; Isabel Spriet
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

7.  Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study.

Authors:  Veronica Milos; Eva Rekman; Åsa Bondesson; Tommy Eriksson; Ulf Jakobsson; Tommy Westerlund; Patrik Midlöv
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

8.  Clinical pharmacist service in the acute ward.

Authors:  Trine Rune Høgh Nielsen; Stig Ejdrup Andersen; Mette Rasmussen; Per Hartvig Honoré
Journal:  Int J Clin Pharm       Date:  2013-08-25

9.  Economic value of pharmacy-led medicines reconciliation at admission to hospital: an observational, UK-based study.

Authors:  Raliat Onatade; Samantha Quaye
Journal:  Eur J Hosp Pharm       Date:  2016-12-09

10.  An admission medication reconciliation programme carried out by pharmacists: impact on surgeons' prescriptions.

Authors:  José Javier Arenas-Villafranca; Manuela Moreno-Santamaría; Carmen López Gómez; Isabel Muñoz Gómez-Millán; Elena Álvaro Sanz; Begoña Tortajada-Goitia
Journal:  Eur J Hosp Pharm       Date:  2018-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.